Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre

Puttegowda, Beeresha; Shivashankarappa, Arun B; Dutta, Suvradip; Chikkamuniswamy, Rama; Bhat, Prabhavathi; Krishnan, Shanmugam; Nanjappa, Manjunath Cholenahally

doi:10.1016/j.ihj.2021.10.007

Cited by 4 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study found an insignificant association between COVID-19 and cerebral infarction, although most existing literature suggests a strong association ( 10 , 56 – 59 ). However, the findings from a multicenter cross-sectional study conducted in the healthcare system in New York State stated that there was no apparent presentation of stroke among patients with COVID-19 ( 14 ).…”

Section: Discussioncontrasting

confidence: 86%

Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study

et al. 2022

View full text Add to dashboard Cite

BackgroundRecent studies have highlighted the cardio-cerebrovascular manifestations of coronavirus disease 2019 (COVID-19).ObjectiveThis study aimed to analyze the likelihood of cardiovascular and cerebrovascular manifestations among patients with COVID-19-positive individuals in South Korea.MethodsA cohort database for COVID-19 from the National Health Insurance Service was used which included patients diagnosed with COVID-19 between January 1 and June 4, 2020. Individuals who tested COVID-19 positive, notwithstanding the severity of the disease, were designated as cases. COVID-19- negative individuals were used as controls for the study. The exclusion criteria included people who had a history of cardiovascular and cerebrovascular diseases between 2015 and 2019. A new diagnosis of cardiovascular and cerebrovascular complications was considered the primary endpoint. The adjusted incidence rate ratio (IRR) of development of complications was estimated using log-link Poisson regression. The model was adjusted at two levels, the first one included age and sex while the second included age, sex, residence area, and level of income. The hazard ratio (HR) was estimated using Cox-proportional hazard regression analysis while adjusting for all demographic variables and covariates.ResultsSignificant results were obtained for acute conditions, such as ischemic heart disease and cerebral hemorrhage. The IRR of COVID-19- positive individuals compared with that of controls for the diagnosis of ischemic heart disease was 1.78 (1.57–2.02; 95% confidence interval [CI]) when adjusted for age and sex. HR was calculated as 3.02 (2.19–4.17; 95% CI) after adjusting for the covariates. In case of cerebral hemorrhage, the adjusted IRR was 2.06 (1.25–3.40; 95% CI) and the adjusted HR was 4.08 (0.90–19.19; 95% CI).ConclusionThe findings of our study suggest that COVID-19 infection can be a significant risk factor for acute cardiovascular complications, such as ischemic heart disease and acute cerebrovascular complications, such as cerebral infarction, after properly adjusting for covariates.

show abstract

Section: Discussioncontrasting

confidence: 86%

Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Hence, elevated levels of troponin above the 99th percentile of the upper limit were used in case selections. Results of the study showed STEMI in 161 patients (31.5%) and NSTEMI in 99 patients (19.4%) [ 34 ].…”

Section: Reviewmentioning

confidence: 99%

COVID-19 and Acute Coronary Syndrome: A Literature Review

Akinrinmade¹,

Obitulata-Ugwu²,

Obijiofor³

et al. 2022

Cureus

View full text Add to dashboard Cite

The coronavirus disease 2019, also known as the COVID-19 pandemic has had a deleterious impact on daily living, with health and socioeconomic effects of a global magnitude. Acute coronary syndrome (ACS), an important cardiovascular disease with significant morbidity and mortality rates, has been frequently reported in patients with this novel virus. This review aims to discuss the potential associations between COVID-19 and ACS with the use of multiple databases, including but not limited to; PubMed, ScienceDirect, World Health Organization, and American Heart Association.We have explored the pathophysiology of ACS, focusing on COVID-19 in particular with the use of various works of literature that highlights the pattern of viral entry and replication via the angiotensin-converting enzyme II. The review has also discussed the impact of the pandemic on hospital admissions, diagnosis, and management of ACS patients, as well as briefly highlighted a possible link between the widely available COVID-19 vaccines and possible cardiovascular complications.The association between COVID-19 and ACS needs more in-depth studies to help establish whether there exists a direct causal and or inciting correlation between them. Understanding this association might lead to new research and treatment options for ACS patients.

show abstract

Assessing risk of major adverse cardiac event among COVID-19 patients using HEART score

et al. 2023

View full text Add to dashboard Cite

Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre

Cited by 4 publications

References 23 publications

Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study

Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study

COVID-19 and Acute Coronary Syndrome: A Literature Review

Assessing risk of major adverse cardiac event among COVID-19 patients using HEART score

Contact Info

Product

Resources

About